Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2022-07-15
Product name:
LINEZOLID INJECTION
Description:
SINGLE USE
DIN:
02461897
Product Monograph/Veterinary Labelling:
Date:
2022-07-06
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
PHARMARIS CANADA INC
102
8310 130th Street
Surrey
British Columbia
Canada
V3W 8J9
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:12.28.24
Anatomical Therapeutic Chemical (ATC): See footnote 4
J01XX08 LINEZOLID
Active ingredient group (AIG) number:See footnote5
0143501003
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| LINEZOLID | 2 MG / ML |